Vistin Pharma ASA banner
V

Vistin Pharma ASA
OSE:VISTN

Watchlist Manager
Vistin Pharma ASA
OSE:VISTN
Watchlist
Price: 21.6 NOK 0.47%
Market Cap: kr957.7m

Wall Street
Price Targets

VISTN Price Targets Summary
Vistin Pharma ASA

There are no price targets for VISTN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Vistin Pharma ASA Competitors:
Price Targets

Revenue
Forecast

11% / Year
Past Growth
-11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
11% / Year
Past Growth
-11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 9 years the compound annual growth rate for Vistin Pharma ASA's revenue is 11%. The projected CAGR for the next 8 years is -11%.

Operating Income
Forecast

17% / Year
Past Growth
-18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
17% / Year
Past Growth
-18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 9 years the compound annual growth rate for Vistin Pharma ASA's operating income is 17%. The projected CAGR for the next 8 years is -18%.

Net Income
Forecast

22% / Year
Past Growth
-11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
22% / Year
Past Growth
-11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 9 years the compound annual growth rate for Vistin Pharma ASA's net income is 22%. The projected CAGR for the next 8 years is -11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VISTN's stock price target?
Not Available

VISTN doesn't have any price targets made by Wall Street professionals.

What is Vistin Pharma ASA's Revenue forecast?
Projected CAGR
-11%

For the last 9 years the compound annual growth rate for Vistin Pharma ASA's revenue is 11%. The projected CAGR for the next 8 years is -11%.

What is Vistin Pharma ASA's Operating Income forecast?
Projected CAGR
-18%

For the last 9 years the compound annual growth rate for Vistin Pharma ASA's operating income is 17%. The projected CAGR for the next 8 years is -18%.

What is Vistin Pharma ASA's Net Income forecast?
Projected CAGR
-11%

For the last 9 years the compound annual growth rate for Vistin Pharma ASA's net income is 22%. The projected CAGR for the next 8 years is -11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett